Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$68.48
-1.61%
Mkt Cap $8.48B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
Implied Upside
+7.8%
Consensus $73.83 vs current $68.48
NASDAQ·Healthcare·Biotechnology
$68.48
-1.61%
Mkt Cap $8.48B
Buy
5
Hold
1
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
+7.8%
Consensus $73.83 vs current $68.48